A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(16 sites)

China

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality

Guangzhou First Peoples Hospital, Guangzhou, Guangdong

Nanfang Hospital Southern Medical University, Guangzhou, Guangdong

Shenzhen Peoples Hospital, Shenzhen, Guangdong

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan